Can Mounjaro Cause a UTI, and What Should You Do About It?

You've started Mounjaro and now something feels off when you use the loo

Most people who search this question have already started treatment and are trying to work out whether what they are experiencing is connected to tirzepatide. It is a fair thing to wonder. Mounjaro slows gastric emptying and suppresses appetite, and in the early weeks nausea, vomiting or loose stools are common, particularly around a dose increase. Those symptoms matter beyond the inconvenience, repeated vomiting or persistent diarrhoea can leave you mildly dehydrated without your noticing, because the thirst signal is often blunted at the same time appetite falls.

Dehydration concentrates urine and reduces its flushing action through the urinary tract. That is a well-established route to bacterial overgrowth in the bladder, entirely separate from any pharmacological effect of tirzepatide itself. So while Mounjaro does not appear to trigger UTIs through its mechanism of action, the side-effect profile in some patients creates conditions that make one more likely. There is a practical check worth building in: look at the colour of your urine once a day. Pale straw is where you want to be. Dark yellow, or noticeably less frequent urination than usual, is a signal to drink more water before anything else.

If you are experiencing burning, frequency, urgency or lower abdominal discomfort, you can find a detailed explanation of the relationship between tirzepatide and urinary symptoms on our page covering Mounjaro and UTIs, but do not put it down to tirzepatide and wait regardless. Contact your prescriber or GP. UTIs are straightforward to treat when caught early and can become more serious if left. The NHS tirzepatide patient information page gives a clear account of which symptoms are expected during treatment and which are not.

Does Mounjaro cause UTIs in people who also have type 2 diabetes?

Tirzepatide is licensed both for weight management and for type 2 diabetes in the UK, so a meaningful proportion of people taking it carry a pre-existing elevated UTI risk. Persistently raised blood glucose affects immune function and alters the urinary environment in ways that favour bacterial growth, that is a diabetes-related phenomenon, not a drug-related one. It is worth knowing about, because it means that a UTI while on Mounjaro may say more about the underlying condition than about the medicine.

There is a separate drug class (SGLT2 inhibitors, sometimes prescribed alongside or instead of GLP-1 medicines for type 2 diabetes) that is strongly associated with UTI and genital infections through its mechanism of excreting glucose into the urine. Tirzepatide does not work this way. If you are on a combination regimen that includes an SGLT2 inhibitor, that drug is a far more likely explanation for urinary symptoms than Mounjaro. Our tirzepatide overview covers how the medicine works in more detail for anyone who wants to understand the distinction.

If you are managing type 2 diabetes alongside weight treatment and something feels wrong, the right step is to speak with your prescriber. At nume, a real clinician reads every message our patients send, questions about new symptoms do not go to a bot. You can reach the team through our support page any day of the week.

What the prescribing information and trial data actually say about tirzepatide side effects

The SURMOUNT-1 trial, which followed more than 2,500 adults over 72 weeks, documented the tirzepatide safety profile carefully. The side effects reported most frequently were gastrointestinal: nausea, diarrhoea, vomiting, constipation, and dyspepsia. UTIs did not emerge as a statistically notable pattern across the programme. The Mounjaro SmPC, which is the definitive prescribing reference reviewed by the MHRA before UK approval, does not list urinary tract infection among the adverse reactions. This does not mean an individual could never experience one while on treatment, but it does mean there is no established pharmacological reason to expect one.

The MHRA issued a Drug Safety Update in January 2026 covering GLP-1 medicines, which reinforced guidance on pancreatitis symptoms and dehydration-related kidney caution. It did not flag UTIs as a concern. The MHRA Yellow Card scheme is worth knowing about: if you experience something unexpected during treatment that you think might be linked to tirzepatide, you can report it directly, and those reports inform ongoing safety monitoring nationally.

For a broader picture of side effects associated with tirzepatide (including which ones are common, which are rare, and which require urgent medical attention) our page on what Mounjaro can cause covers the full landscape clearly. There is also a detailed look at the gastrointestinal effects specifically on our page on Mounjaro and IBS-type symptoms, since the two are sometimes confused by patients in the early weeks.

When to get medical help, and how tirzepatide fits into your broader care

Seek prompt medical attention if you develop burning or pain when urinating, a need to go very frequently with little output, cloudy or foul-smelling urine, lower abdominal pain, or fever with back or flank pain. The last combination, in particular, can indicate a kidney infection that needs treatment the same day rather than a watch-and-wait approach. None of these are listed as expected effects of tirzepatide; they are symptoms in their own right and should be assessed on those terms.

If you are on Mounjaro and want to check whether your current weight-loss treatment plan is still the right one, or you have questions about symptoms you are experiencing, our consultation pathway connects you with a GPhC-registered prescriber who can review your situation properly. Every review is clinical, not automated. For broader reading on what drives the cost and structure of private tirzepatide treatment in the UK, our coverage of the Eli Lilly UK price change gives useful context. And if you are still in the early stages of understanding whether Mounjaro might be suitable for you, our Mounjaro overview is a good starting point before you speak to a prescriber.